Literature DB >> 35411100

Longitudinal associations of pre-pregnancy BMI and gestational weight gain with maternal urinary metabolites: an NYU CHES study.

Sara E Long1, Melanie H Jacobson2, Yuyan Wang3, Mengling Liu3,4, Yelena Afanasyeva2,3, Susan J Sumner5,6, Susan McRitchie6, David R Kirchner6, Sara G Brubaker7, Shilpi S Mehta-Lee7, Linda G Kahn2,3, Leonardo Trasande2,3,4,8,9.   

Abstract

BACKGROUND/
OBJECTIVES: Excessive gestational weight gain (GWG) and pre-pregnancy obesity affect a significant portion of the US pregnant population and are linked with negative maternal and child health outcomes. The objective of this study was to explore associations of pre-pregnancy body mass index (pBMI) and GWG with longitudinally measured maternal urinary metabolites throughout pregnancy. SUBJECTS/
METHODS: Among 652 participants in the New York University Children's Health and Environment Study, a longitudinal pregnancy cohort, targeted metabolomics were measured in serially collected urine samples throughout pregnancy. Metabolites were measured at median 10 (T1), 21 (T2), and 29 (T3) weeks gestation using the Biocrates AbsoluteIDQ® p180 Urine Extension kit. Acylcarnitine, amino acid, biogenic amine, phosphatidylcholine, lysophosphatidylcholine, sphingolipid, and sugar levels were quantified. Pregnant people 18 years or older, without type 1 or 2 diabetes and with singleton live births and valid pBMI and metabolomics data were included. GWG and pBMI were calculated using weight and height data obtained from electronic health records. Linear mixed effects models with interactions with time were fit to determine the gestational age-specific associations of categorical pBMI and continuous interval-specific GWG with urinary metabolites. All analyses were corrected for false discovery rate.
RESULTS: Participants with obesity had lower long-chain acylcarnitine levels throughout pregnancy and lower phosphatidylcholine and glucogenic amino acids and higher phenylethylamine concentrations in T2 and T3 compared with participants with normal/underweight pBMI. GWG was associated with taurine in T2 and T3 and C5 acylcarnitine species, C5:1, C5-DC, and C5-M-DC, in T2.
CONCLUSIONS: pBMI and GWG were associated with the metabolic environment of pregnant individuals, particularly in relation to mid-pregnancy. These results highlight the importance of both preconception and prenatal maternal health.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35411100      PMCID: PMC9581342          DOI: 10.1038/s41366-022-01116-0

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.551


  58 in total

1.  Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis.

Authors:  I Cetin; C Corbetta; L P Sereni; A M Marconi; P Bozzetti; G Pardi; F C Battaglia
Journal:  Am J Obstet Gynecol       Date:  1990-01       Impact factor: 8.661

2.  Placental release of taurine to both the maternal and fetal circulations in human term pregnancies.

Authors:  Maia Blomhoff Holm; Oddrun Kristiansen; Ane Moe Holme; Nasser Ezzatkhah Bastani; Hildegunn Horne; Rune Blomhoff; Guttorm Haugen; Tore Henriksen; Trond Melbye Michelsen
Journal:  Amino Acids       Date:  2018-06-01       Impact factor: 3.520

Review 3.  Inflammation in maternal obesity and gestational diabetes mellitus.

Authors:  P Pantham; I L M H Aye; T L Powell
Journal:  Placenta       Date:  2015-04-28       Impact factor: 3.481

4.  Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes.

Authors:  Victoria Sandler; Anna C Reisetter; James R Bain; Michael J Muehlbauer; Michael Nodzenski; Robert D Stevens; Olga Ilkayeva; Lynn P Lowe; Boyd E Metzger; Christopher B Newgard; Denise M Scholtens; William L Lowe
Journal:  Diabetologia       Date:  2016-12-16       Impact factor: 10.122

5.  Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.

Authors:  Stephanie J Mihalik; Bret H Goodpaster; David E Kelley; Donald H Chace; Jerry Vockley; Frederico G S Toledo; James P DeLany
Journal:  Obesity (Silver Spring)       Date:  2010-01-28       Impact factor: 5.002

Review 6.  Association between perinatal outcomes and maternal pre-pregnancy body mass index.

Authors:  P Liu; L Xu; Y Wang; Y Zhang; Y Du; Y Sun; Z Wang
Journal:  Obes Rev       Date:  2016-08-18       Impact factor: 9.213

7.  Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI.

Authors:  H W Moises; P Waldmeier; H Beckmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

8.  Maternal Obesity and Risk of Low Birth Weight, Fetal Growth Restriction, and Macrosomia: Multiple Analyses.

Authors:  Małgorzata Lewandowska
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

9.  Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction.

Authors:  Jezid Miranda; Rui V Simões; Cristina Paules; Daniel Cañueto; Miguel A Pardo-Cea; María L García-Martín; Francesca Crovetto; Rocio Fuertes-Martin; Monica Domenech; María D Gómez-Roig; Elisenda Eixarch; Ramon Estruch; Stefan R Hansson; Nuria Amigó; Nicolau Cañellas; Fatima Crispi; Eduard Gratacós
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

10.  Longitudinal Plasma Metabolomics Profile in Pregnancy-A Study in an Ethnically Diverse U.S. Pregnancy Cohort.

Authors:  Susanna D Mitro; Jing Wu; Mohammad L Rahman; Yaqi Cao; Yeyi Zhu; Zhen Chen; Liwei Chen; Mengying Li; Stefanie N Hinkle; Andrew A Bremer; Natalie L Weir; Michael Y Tsai; Yiqing Song; Katherine L Grantz; Bizu Gelaye; Cuilin Zhang
Journal:  Nutrients       Date:  2021-09-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.